Home › Funds › Vivo Capital, LLC › ENTX

Vivo Capital, LLC position in ENTX

Entera Bio Ltd · Health Care

Vivo Capital, LLC reported holding 12,254,901 shares of ENTX (Entera Bio Ltd) in its Q3 2026 13F filing — a position valued at US$35.7M, representing 4.05% of its reported portfolio and ranking #6 among its reported holdings. Vivo Capital, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)12.25M sh
Reported value held$35.66M
Portfolio Weight4.05%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ENTX position evolved

Vivo Capital, LLC first disclosed a stake in ENTX in Q3 2026 at 12,254,901 shares (US$35.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 12.25M $35.66M New

About ENTX and 13F data

ENTX (Entera Bio Ltd) is a Health Care company. 29 other funds we track also report a position in ENTX — the largest reported positions include Knoll Capital Management, LLC (US$10.4M), NEXTBio Capital Management LP (US$8.5M), BVF INC/IL (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENTX

All ENTX fund holders →

FAQ

How long has Vivo Capital, LLC held ENTX?

Vivo Capital, LLC has disclosed ENTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in ENTX?

As of Q3 2026, Vivo Capital, LLC holds 12.25M shares of ENTX (Entera Bio Ltd), valued at $35.66M, representing 4.05% of its reported portfolio and ranking #6.

Has Vivo Capital, LLC been buying or selling ENTX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in ENTX.

Which other funds hold ENTX?

Other major institutional holders of ENTX include Knoll Capital Management, LLC, NEXTBio Capital Management LP, BVF INC/IL, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.